Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 1 of the last 4 fiscal years.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 41 % of short-term debt in 2025; threshold 65 %.
-
Board fully replaced NBB
No director from three years ago is still active according to annual account 2025.
Financials
Financial year 2025
EUROPHARMACEUTICALS from Ukkel, company number BE0425594923, closed financial year 2025 with a result of € -19,213 after tax. For that financial year EUROPHARMACEUTICALS recorded a gross margin of € -15,369 and equity of € -2,911. Compared with financial year 2024, the result moved from € -15,668 to € -19,213. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 16, 2026.
€ -2,911
▼ € 19,213 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -19,213
▼ 23 % more loss than in 2024
Profit after tax over the fiscal year.
€ 22,171
▲ 10% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -64,911.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 67
▼ 69% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 543
▲ 185% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 8,671 | € 37,687 | € -3,265 | € -15,369 | ▼ € 12,104 |
| Profit after taxes | € -4,658 | € 25,308 | € -15,668 | € -19,213 | ▼ € 3,545 |
| Equity | € 6,662 | € 31,970 | € 16,302 | € -2,911 | ▼ € 19,213 |
| Total debts | € 67,635 | € 54,859 | € 50,317 | € 57,484 | ▲ 14% |
| Cash | € 9,454 | € 14,506 | € 20,103 | € 22,171 | ▲ 10% |
| Retained profit | € -55,338 | € -30,030 | € -45,698 | € -64,911 | ▼ € 19,213 |
| Bank debt | € 14,376 | € 2,055 | € 0 | € 0 | |
| Balance sheet total | € 74,296 | € 86,829 | € 66,619 | € 54,573 | ▼ 18% |
By gross margin, EUROPHARMACEUTICALS ranks 11th of 11 companies with main activity “Groothandel in farmaceutische en medische artikelen” in Ukkel that publish figures (fiscal year 2025).
Key figures of EUROPHARMACEUTICALS, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
Ask about EUROPHARMACEUTICALS the way you would ask their accountant.
Answers from the filed annual accounts, the Belgian Official Gazette and the CBE register.
Connect ChatGPT or Claude for free- ChatGPT
- Claude
Free account, no payment card. Key figures unlimited, the annual accounts and deeds of 10 companies a month. Need more? Get in touch, we are looking for our first pilot users.
What happened to EUROPHARMACEUTICALS?
What happened at EUROPHARMACEUTICALS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 19,213. Source: NBB ↗
- Marie-Laurence Geczy stepped down as director. NBB
- Marie-Laurence Geczy became a director. NBB
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
In short
From € 4,658 loss in 2022 to € 19,213 loss in 2025.
Paid € 986 in corporate taxes since 2022.
Best year ever: 2023, with € 25,308 profit.
Management
Behind EUROPHARMACEUTICALS is Jozsef GECZY.
Directors
According to the 2025 annual accounts
Jozsef GECZY
Director
Marie-Laurence Geczy
Director
since 2006 · until 2025
Establishments
Establishment units
Physical locations of this company
Wolvendaellaan 21 box 6
1180 Ukkel
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Similar companies in Ukkel
Same main activity (Groothandel in farmaceutische en medische artikelen), 14 active companies in Ukkel, largest first.
€ 16.8 million revenue · 2025
€ 12.1 million revenue · 2025
€ 1.1 million gross margin · 2025
€ 343,333 gross margin · 2025
€ 18,439 gross margin · 2025
COMPAGNIE INTERNATIONALE DE DISTRIBUTION
€ 11,638 gross margin · 2025
Details
- Company number
- 0425.594.923
- VAT number
- BE 0425.594.923
- Registered office
- Wolvendaellaan 21 bus 6, 1180 Ukkel
- Names & denominations
- EUROPHARMACEUTICALS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 29 March 1984
- Peppol
- Active · Active since 21 Aug 2025
- Activities · NACE
Groothandel in farmaceutische en medische artikelen
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Vervaardiging van geneesmiddelen
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering